Findings show Black women face higher cervical cancer risks. Learn about the crucial factors behind these statistics and how ...

The alarming data can get anyone to wonder whether or not all HPV infections progress to cancer or if it is just some ...

HPV vaccines aim to prevent the development of HPV-related cancers by stopping the viral infection from taking hold in the ...

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.

Medically reviewed by Khadeja Haye, MD The human papillomavirus (HPV) vaccine is recommended for people ages 9 to 26. Most ...

Human papillomavirus (HPV) remains one of the most prevalent viral infections globally, affecting millions across ...

In 2022, 79,906 women died due to cervical cancer. Know more about the challenges, treatment, prevention and progress of ...

Fewer than half of women who tested positive for HPV with negative cytological findings returned for a surveillance co-test within 1 year as recommended, yet more than half of those who received ...

Human Papilloma Virus (HPV) self-sampling promises to make the process of screening for cervical cancer easier, more ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

India faces a rising health issue with millions of cervical cancer patients, largely caused by the HPV virus. The HPV vaccine ...

Dr Nur Adila Mokhtar, Consultant Clinical Oncologist at OncoCare Cancer Centre Malaysia, shares, “The HPV vaccine is ...